Cervical cancer screening continues to limit provision of contraception

Contraception

Volumn 72, Issue 3, 2005, Pages 179-181

  Schwarz, Eleanor Bimla ^a,d   Saint, Mona ^b   Gildengorin, Ginny ^a   Weitz, Tracy A ^a,c   Stewart, Felicia H ^a,c   Sawaya, George F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Kaiser Permanente Northern California ^*  (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cervical cancer screening; Contraception; Emergency contraception; Pap testing

Indexed keywords

ORAL CONTRACEPTIVE AGENT; POSTCOITUS CONTRACEPTIVE AGENT;

ARTICLE; CANCER SCREENING; CONTRACEPTION; DRUG USE; DRUG UTILIZATION; EMERGENCY CONTRACEPTION; FEMALE; GYNECOLOGY; HUMAN; NON PROFIT ORGANIZATION; NORMAL HUMAN; OBSTETRICS; PAPANICOLAOU TEST; PRACTICE GUIDELINE; PRESCRIPTION; QUESTIONNAIRE; UNITED STATES; UTERINE CERVIX CANCER; UTERINE CERVIX DYSPLASIA;

CONTRACEPTION; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVES, ORAL; CONTRACEPTIVES, POSTCOITAL; FEMALE; HUMANS; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS; PRESCRIPTIONS, DRUG; QUESTIONNAIRES; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 23644444167     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2005.04.009     Document Type: Article

References (8)

1. L.A.G. Ries, C.L. Kosary, B.F. Hankey, B.A. Miller, L. Clegg, and B.K. Edwards SEER Cancer Statistics Review, 1973-1994 1997 National Cancer Institute Bethesda (Md) [NIH Pub. No. 97-2789]
2. F.H. Stewart, C.C. Harper, C.E. Ellertson, D.A. Grimes, G.F. Sawaya, and J. Trussell Clinical breast and pelvic examination requirements for hormonal contraception: current practice vs. evidence JAMA 285 2001 2232 2239
3. M. Saint, G. Gildengorin, and G.F. Sawaya Current cervical neoplasia screening practices of obstetrician/gynecologists in the United States Am J Obstet Gynecol 192 2005 414 4121
4. D. Saslow, C.D. Runowicz, and D. Solomon American Cancer Society guideline for the early detection of cervical neoplasia and cancer CA Cancer J Clin 52 2002 342 362
5. H. von Hertzen, G. Piaggio, and J. Ding Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial Lancet 360 2002 1803 1810
6. C. Ellertson, M. Evans, and S. Ferden Extending the time limit for starting the Yuzpe regimen of emergency contraception to 120 hours Obstet Gynecol 101 2003 1168 1171
7. L.B. Finer, and S.K. Henshaw Abortion incidence and services in the United States in 2000 Perspect Sex Reprod Health 35 2003 6 15
8. D.A. Asch, M.K. Jedrziewski, and N.A. Christakis Response rates to mail surveys published in medical journals J Clin Epidemiol 50 1997 1129 1136